The DNA methyltransferase inhibitor, guadecitabine, targets tumor-induced myelopoiesis and recovers T cell activity to slow tumor growth in combination with adoptive immunotherapy in a mouse model of breast cancer is a research paper published in Research Square (2020). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
National Institutes of Health
Grant: 3P30CA016059-39S5
VCU Massey Cancer Center Support Grant
National Institutes of Health
Grant: 4P30CA016059-35
Massey Cancer Center Support Grant
Fields of Study
Keywords
Sustainable Development Goals